🇺🇸 FDA
Patent

US 8921536

HCV vaccines and methods for using the same

granted A61KA61K2039/53A61K2039/57

Quick answer

US patent 8921536 (HCV vaccines and methods for using the same) held by Inovio Pharmaceuticals, Inc. expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/53, A61K2039/57, A61K31/711, A61K38/00